Logotype for Ensysce Biosciences Inc

Ensysce Biosciences (ENSC) investor relations material

Ensysce Biosciences Proxy Filing summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Ensysce Biosciences Inc
Proxy Filing summary2 Dec, 2025

Executive summary

  • Annual Meeting scheduled for December 23, 2025, to be held virtually, with record date set as October 29, 2025.

  • Key proposals include approval of securities issuance, incentive plan amendment, director elections, auditor ratification, and potential adjournment for further proxy solicitation.

  • Board recommends voting “FOR” all proposals, citing capital needs, competitive compensation, and governance best practices.

Voting matters and shareholder proposals

  • Proposal 1 seeks approval for full issuance of common stock and warrants to an investor, potentially increasing outstanding shares by over 20% and diluting current shareholders.

  • Proposal 2 requests an increase in shares available under the 2021 Omnibus Incentive Plan from 121,457 to 721,457.

  • Proposal 3 involves electing two Class I directors for terms expiring at the 2028 Annual Meeting.

  • Proposal 4 is to ratify Baker Tilly US, LLP as the independent registered public accounting firm for 2025.

  • Proposal 5 allows adjournment of the meeting to solicit additional proxies if needed.

Board of directors and corporate governance

  • Board will reduce from eight to seven members due to a director retirement, maintaining three classes of staggered terms.

  • Majority of directors are independent under Nasdaq rules; board committees include audit, compensation, and nominating/governance.

  • Board leadership separates CEO and Chair roles, with guidelines for governance, succession planning, and board evaluations.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Ensysce Biosciences earnings date

Logotype for Ensysce Biosciences Inc
Q4 202510 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Ensysce Biosciences earnings date

Logotype for Ensysce Biosciences Inc
Q4 202510 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Ensysce Biosciences Inc. is a clinical-stage pharmaceutical company focused on developing innovative drug delivery technologies aimed at improving safety in pain management. The company is known for its development of two proprietary platforms: the Trypsin Activated Abuse Protection (TAAP) and Multi-Pill Abuse Resistance (MPAR). These platforms are designed to reduce the risks associated with prescription opioid misuse, abuse, and overdose by enhancing the safety of oral drug delivery. Ensysce's product pipeline includes prodrug technologies that aim to provide effective pain relief while mitigating the potential for abuse and overdose. The company is headquartered in La Jolla, California, and its shares are listed on the NASDAQ under the ticker symbol ENSC.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage